The TCF7L2 Gene Polymorphisms and the Relationship between TCF7L2 Gene and Type 2 Diabetes: A review

被引：0
|
作者：
Zhang Zhong [1 ]
Xie Yue [1 ]
Gao Zhi-Mou [1 ]
机构：
[1] Maoming Univ, Coll Chem & Life Sci, Maoming 525000, Peoples R China
来源：
PROCEEDINGS OF 2009 INTERNATIONAL CONFERENCE OF NATURAL PRODUCT AND TRADITIONAL MEDICINE, VOLS 1 AND 2 | 2009年
关键词：
type; 2; diabetes; TCF7L2; rs7903146; rs12255372; mechanism; INSULIN-SECRETION; RISK; VARIANTS; WNT; ASSOCIATION; PROINSULIN; EXPRESSION; SUSCEPTIBILITY; REPLICATION; MECHANISMS;
D O I：
暂无
中图分类号：
R [医药、卫生];
学科分类号：
10 ;
摘要：
Emerging evidence indicates that,variation in the transcription factor 7-like 2(TCF7L2) gene may play a role in the pathogenesis of type 2 diabetes. The paper was to focus on review the polymorphisms of transcription factor 7-like-2 (TCF7L2) and the possible mechanism that TCF7L2 causes type 2 diabetes. The genetic effects of TCF7L2 have been replicated with remarkable consistency across various populations and stand out as having by far the biggest effect on diabetes risk. There are five single nucleotide polymorphisms (SNPs) of TCF7L2 connecting with Type 2 diabetes, especially the two SNPs (rs7903146 and rs12255372), which have been confirmed in many experiments. The possible mechanism that TCF7L2 causes type 2 diabetes may help to treat and restrain type 2 diabetes.
引用
收藏
页码：377 / 383
页数：7
相关论文
共 50 条
  • [31] The accelerator hypothesis cannot be tested using the type 2 diabetes gene, TCF7L2
    Wilkin, T. J.
    DIABETOLOGIA, 2007, 50 (08) : 1780 - 1780
  • [32] TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program
    Florez, Jose C.
    Jablonski, Kathleen A.
    Bayley, Nick
    Pollin, Toni I.
    de Bakker, Paul I. W.
    Shuldiner, Alan R.
    Knowler, William C.
    Nathan, David M.
    Altshuler, David
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (03): : 241 - 250
  • [33] The accelerator hypothesis cannot be tested using the type 2 diabetes gene, TCF7L2
    T. J. Wilkin
    Diabetologia, 2007, 50 : 1780 - 1780
  • [34] An alternative effector gene at the type 2 diabetes-associated TCF7L2 locus?
    Martijn van de Bunt
    Diabetologia, 2016, 59 : 2292 - 2294
  • [35] Type 2 Diabetes Susceptibility Gene TCF7L2 and Its Role in β-Cell Function
    Gloyn, Anna L.
    Braun, Matthias
    Rorsman, Patrik
    DIABETES, 2009, 58 (04) : 800 - 802
  • [36] Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution
    Agnar Helgason
    Snæbjörn Pálsson
    Gudmar Thorleifsson
    Struan F A Grant
    Valur Emilsson
    Steinunn Gunnarsdottir
    Adebowale Adeyemo
    Yuanxiu Chen
    Guanjie Chen
    Inga Reynisdottir
    Rafn Benediktsson
    Anke Hinney
    Torben Hansen
    Gitte Andersen
    Knut Borch-Johnsen
    Torben Jorgensen
    Helmut Schäfer
    Mezbah Faruque
    Ayo Doumatey
    Jie Zhou
    Robert L Wilensky
    Muredach P Reilly
    Daniel J Rader
    Yu Bagger
    Claus Christiansen
    Gunnar Sigurdsson
    Johannes Hebebrand
    Oluf Pedersen
    Unnur Thorsteinsdottir
    Jeffrey R Gulcher
    Augustine Kong
    Charles Rotimi
    Kári Stefánsson
    Nature Genetics, 2007, 39 : 218 - 225
  • [37] Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution
    Helgason, Agnar
    Palsson, Snaebjorn
    Thorleifsson, Gudmar
    Grant, Struan F. A.
    Emilsson, Valur
    Gunnarsdottir, Steinunn
    Adeyemo, Adebowale
    Chen, Yuanxiu
    Chen, Guanjie
    Reynisdottir, Inga
    Benediktsson, Rafn
    Hinney, Anke
    Hansen, Torben
    Andersen, Gitte
    Borch-Johnsen, Knut
    Jorgensen, Torben
    Schaefer, Helmut
    Faruque, Mezbah
    Doumatey, Ayo
    Zhou, Jie
    Wilensky, Robert L.
    Reilly, Muredach P.
    Rader, Daniel J.
    Bagger, Yu
    Christiansen, Claus
    Sigurdsson, Gunnar
    Hebebrand, Johannes
    Pedersen, Oluf
    Thorsteinsdottir, Unnur
    Gulcher, Jeffrey R.
    Kong, Augustine
    Rotimi, Charles
    Stefansson, Kari
    NATURE GENETICS, 2007, 39 (02) : 218 - 225
  • [38] Regulation of the TMEPAI promoter by TCF7L2: the C-terminal tail of TCF7L2 is essential to activate the TMEPAI gene
    Nakano, Naoko
    Kato, Mitsuyasu
    Itoh, Susumu
    JOURNAL OF BIOCHEMISTRY, 2016, 159 (01): : 27 - 30
  • [39] Association of TCF7L2 with Type 2 diabetes in a Cameroonian population
    Fokeng, M. Guewo
    Sobngwi, E.
    Sontsa, O. Donfack
    Ndonwi, E. N.
    Mato, E. P. Mofo
    Pokam, P. Fosso
    Djahmeni, E.
    Tiedeu, B. Atogho
    Evehe, M. S.
    Djokam-Dadjeu, R.
    Aminkeng, F.
    Mbacham, W. F.
    Mbanya, J. C.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 103 : S33 - S33
  • [40] PPAR(sic)2, aldose reductase, and TCF7L2 gene polymorphisms: relation to diabetes mellitus
    Shawki, Hadeel Ahmed
    Abo-hashem, Ekbal M.
    Youssef, Magdy M.
    Shahin, Maha
    Elzehery, Rasha
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2022, 21 (01) : 241 - 250
12345